容百科技(688005.SH)業績快報:2023年淨利潤5.93億元,同比下降56.17%
格隆匯1月24日丨容百科技(688005.SH)公佈2023年年度業績快報公吿,公司2023年度營業總收入228.73億元,同比下降24.07%;歸屬於母公司所有者的淨利潤5.93億元,同比下降56.17%;歸屬於母公司所有者的扣除非經常性損益的淨利潤5.33億元,同比下降59.51%;基本每股收益1.29元。
2023年,公司三元正極材料出貨持續增長,約10萬噸,同比增長11%,全球市佔率超10%,連續三年保持行業首位。期間,配合4680大圓柱電池的量產上車,公司三元產品結構得到進一步優化,超高鎳9系產品出貨近萬噸,進一步夯實了公司在高鎳領域的壁壘優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.